Evidence map›Paper›PMID 22653878›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2012

Hormonal and chemical regulation of paraoxonases in mice.

Xingguo Cheng, Curtis D Klaassen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Paraoxonases at the Heart of Neurological Disorders.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Developmental expression of paraoxonase 2.Chemico-biological interactions · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xingguo ChengDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
Curtis D Klaassen
University of Kansas · USUniversity of Kansas Medical Center · US

Funding

THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLASSEN, CURTIS D · 2006 to 2011
$12.1M
Regulation of Hepatic Uptake of Endogenous Signaling Molecules and XenobioticsR01ES009649 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CSANAKY, IVAN · 2000 to 2014
$4.0M
Developmental Regulation of Drug Processing GenesR01ES019487 · NIEHS · UNIVERSITY OF WASHINGTON · PI CUI, JULIA YUE, LU, HONG · 2010 to 2014
$3.0M
Nrf2 as a Master Regulator in Liver Disease Prevention and TherapyR01DK081461 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2009 to 2012
$1.3M
NCRR NIH HHS P20 RR021940NCRR NIH HHS RR021940NIDDK NIH HHS DK081461NIDDK NIH HHS R01 DK081461NIEHS NIH HHS ES019487NIEHS NIH HHS ES09649NIEHS NIH HHS R01 ES009649NIEHS NIH HHS R01 ES019487
6 · The paper itself

Abstract

In humans and rodents, paraoxonase (PON/Pon) 1 expression and activity in livers and serum are higher in females than in males, and some drugs increase paraoxonase's expression. However, the underlining mechanisms of gender-divergent expression and chemical regulation of Pon1 remain largely unknown. The present study determined the regulatory mechanisms contributing to gender-divergent and chemically altered Pon expression in mouse livers. Pon1 mRNA was much more abundant in the livers of mice than other tissues, with higher levels in female livers than male livers at mRNA and protein levels. Pon2 mRNA was ubiquitously expressed in mouse tissues, but minimally in mouse liver. Pon3 mRNA was most abundant in mouse lung and liver and less abundant in other tissues. Pon1 mRNA was lowest in fetal liver, markedly increased at parturition, and remained relatively constant thereafter. Pon2 and Pon3 mRNA are highly expressed in fetal liver and decreased after birth. Male-pattern growth hormone (GH) administration in hypophysectomized and lit/lit mice decreased Pon1 expression. Sex hormones and female-pattern GH administration had no effect on Pon1 expression, indicating the importance of male-pattern GH in regulating Pon1. Aryl hydrocarbon receptor, pregnane X receptor, and NF-E2-related factor activators had no effect on Pon1 mRNA. A constitutive androstane receptor (CAR) activator decreased Pon1 expression in wild-type but not CAR-null mice. In conclusion, Pon1 mRNA was most abundant in adult mouse livers, whereas Pon2 and Pon3 mRNAs were most abundant in fetal mouse livers. Female-predominant Pon1 expression in mouse livers is caused by the inhibitory effects of male-pattern GH secretion, and CAR activation decreases Pon1 expression.

Indexed as

AnimalsAryldialkylphosphataseConstitutive Androstane ReceptorFemaleGonadal Steroid HormonesGrowth HormoneLiverLungMaleMiceMice, Inbred C57BLNF-E2 Transcription FactorPregnane X ReceptorPyridinesReceptors, Aryl HydrocarbonReceptors, Cytoplasmic and Nuclear1,4-bis(2-(3,5-dichloropyridyloxy))benzeneAryldialkylphosphataseConstitutive Androstane ReceptorGonadal Steroid HormonesGrowth HormoneNF-E2 Transcription FactorPON1 protein, mousePON3 protein, mousePregnane X ReceptorPyridinesReceptors, Aryl HydrocarbonReceptors, Cytoplasmic and NuclearReceptors, SteroidRNA, Messenger

Identifiers

PMID22653878
PMCPMC3422525
OpenAlexW2124199446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.